Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

NeoMedix Corporation
Profile last edited on: 1/30/13      CAGE: 48NF5      UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1993
First Award
2003
Latest Award
2003
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

15042 Parkway Loop Suite A
Tustin, CA 92780
   (714) 258-8355
   info@neomedix.net
   www.neomedix.net
Location: Single
Congr. District: 45
County: Orange

Public Profile

NeoMedix Corporation has developed Trabectome, an FDA-cleared, minimally invasive medical device technology for the treatment of open angel glaucoma. In 2004, the firm anounced FDA clearance of its new Trabectome™ technology for the treatment of Glaucoma

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$148,045
Phase II Dollars
$0
Total Awarded
$148,045

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2003 1 NIH $148,045
Project Title: Minimally Invasive Glaucoma Surgical Instrument

Key People / Management

  Michael Mittelstein -- President

  Soheila Mirhashemi

Company News

There are no news available.